Abstract
Transcranial magnetic stimulation (TMS) is a safe and easy technique for stimulating neurons in the human central nervous system. Studies combining TMS with drugs in healthy subjects and patients have advanced our knowledge of how TMS activates brain circuits and led to new techniques for evaluating the function of specific systems. For example, TMS techniques can detect effects on axon membranes, glutamatergic and GABAergic synapses and the influence of catecholaminergic systems, as well as group differences due to genetic variations in the response to drugs. With this knowledge base, TMS can now be used to explore and compare the effects of drugs on brain systems and may also serve as a surrogate for behavioral responses in clinical trials.
Keywords: Transcranial magnetic stimulation (single pulse), transcranial magnetic stimulation (paired pulse), drug physiological effects, neurotransmitter agents, gaba, glutamate, monoamines, biogenic
Central Nervous System Agents in Medicinal Chemistry
Title: Transcranial Magnetic Stimulation in Clinical Pharmacology
Volume: 8 Issue: 4
Author(s): Dimitrios Kapogiannis and Eric M. Wassermann
Affiliation:
Keywords: Transcranial magnetic stimulation (single pulse), transcranial magnetic stimulation (paired pulse), drug physiological effects, neurotransmitter agents, gaba, glutamate, monoamines, biogenic
Abstract: Transcranial magnetic stimulation (TMS) is a safe and easy technique for stimulating neurons in the human central nervous system. Studies combining TMS with drugs in healthy subjects and patients have advanced our knowledge of how TMS activates brain circuits and led to new techniques for evaluating the function of specific systems. For example, TMS techniques can detect effects on axon membranes, glutamatergic and GABAergic synapses and the influence of catecholaminergic systems, as well as group differences due to genetic variations in the response to drugs. With this knowledge base, TMS can now be used to explore and compare the effects of drugs on brain systems and may also serve as a surrogate for behavioral responses in clinical trials.
Export Options
About this article
Cite this article as:
Kapogiannis Dimitrios and Wassermann M. Eric, Transcranial Magnetic Stimulation in Clinical Pharmacology, Central Nervous System Agents in Medicinal Chemistry 2008; 8 (4) . https://dx.doi.org/10.2174/187152408786848076
DOI https://dx.doi.org/10.2174/187152408786848076 |
Print ISSN 1871-5249 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6166 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Mitochondrial Dysfunction and Antioxidant Therapy in Sepsis
Infectious Disorders - Drug Targets Geriatric Depression - Review for Primary Care
Current Psychiatry Reviews VEGF Signal System: The Application of Antiangiogenesis
Current Medicinal Chemistry Analgesic Drug Use Associated with Statin Prescription – A Cross- Sectional Study in Primary Care Settings
Current Drug Safety Resting-State Networks in Schizophrenia
Current Topics in Medicinal Chemistry Computational and Kinetic Studies of Acetylcholine Esterase Inhibition by Phenserine
Current Pharmaceutical Design P2Y Receptor Activation Affects the Proliferation and Differentiation of Glial and Neuronal Cells: A Focus on Rat C6 Glioma Cells
Current Neuropharmacology Proceeding of the 8th Alcohol Hangover Research Group Meeting
Current Drug Abuse Reviews Improvement of the Mechanical and Thermal Properties of Bayfol CR6-2 Polymer using UV Radiation
Recent Patents on Mechanical Engineering Serotonergic Modulation of Spinal Sensory Circuits
Current Topics in Medicinal Chemistry The Implications of Sortilin/Vps10p Domain Receptors in Neurological and Human Diseases
CNS & Neurological Disorders - Drug Targets An Overview of the Current and Novel Drugs for Alzheimers Disease with Particular Reference to Anti-Cholinesterase Compounds
Current Pharmaceutical Design Application of Molecule-Ion Interactions Between Cyclodextrins and Ions in Inorganic Nanochemistry
Current Organic Chemistry Metal Nanoparticles for the Treatment and Diagnosis of Neurodegenerative Brain Diseases
Current Pharmaceutical Design Pretreatment with Huperzine A Protects Acetylcholinesterase in the Rat Brain Against Inhibition by VX and Russian VX
Letters in Drug Design & Discovery Women and Schizophrenia: Sex-Based Pharmacotherapy
Current Psychiatry Reviews Mesenchymal Stem Cells: Key Actors in Tumor Niche
Current Stem Cell Research & Therapy Photopolymerizable Resins for 3D-Printing Solid-Cured Tissue Engineered Implants
Current Drug Targets ACE Inhibition of Plant Alkaloids Targeted Approach for Selective Inhibition
Mini-Reviews in Organic Chemistry Microdose Lithium Treatment Stabilized Cognitive Impairment in Patients with Alzheimer’s Disease
Current Alzheimer Research